See All Slides - tctmd.com

Slides

Presentation TCT 2013

Status Update on European Medical Device Regulatory Reform Initiatives

Presenter: Alan Fraser

October 30, 2013

Presentation TCT 2013

Current Landscape, Opportunities and Challenges for Drug-Coated Balloon Technologies

Presenter: Juan Granada

October 31, 2013

Presentation TCT 2013

TRILOGY-ACS Recap and Emerging Data: Implications for Current Prasugrel Use

Presenter: E. Magnus Ohman

October 31, 2013

Presentation TCT 2013

Platelet Function and Genetic Testing are Currently Worthless

Presenter: Daniel Simon

October 31, 2013

Presentation TCT 2013

Acute Coronary Syndromes Including STEMI: Is There a Need and a Role for Drug-Coated Balloons?

Presenter: Pieter Stella

October 31, 2013

Presentation TCT 2013

Tips and Tricks to Deploy Bioresorbable Scaffolds

Presenter: Alexandre Abizaid

October 31, 2013

Presentation TCT 2013

Use of Clopidogrel with or without Aspirin in Patients Taking Oral Anticoagulant Therapy and Undergoing Percutaneous Coronary Intervention: an Open-Label, Randomized, Controlled...

Presenter: Freek Verheugt

October 31, 2013

Presentation TCT 2013

How to Identify Elevated Genetic Risk for Failed AF Ablation (4q25)

Presenter: Paddy Barrett

October 31, 2013

Presentation TCT 2013

Which High-Risk AS Patients Should be Treated with TAVR and Which are Better Suited for Surgical AVR

Presenter: Neil Moat

October 27, 2013

Presentation TCT 2013

PFM

Presenter: Alexander Javois

October 27, 2013

Advertisement

Slides

Status Update on European Medical Device Regulatory Reform Initiatives

Current Landscape, Opportunities and Challenges for Drug-Coated Balloon Technologies

TRILOGY-ACS Recap and Emerging Data: Implications for Current Prasugrel Use

Platelet Function and Genetic Testing are Currently Worthless

Acute Coronary Syndromes Including STEMI: Is There a Need and a Role for Drug-Coated Balloons?

Tips and Tricks to Deploy Bioresorbable Scaffolds

Use of Clopidogrel with or without Aspirin in Patients Taking Oral Anticoagulant Therapy and Undergoing Percutaneous Coronary Intervention: an Open-Label, Randomized, Controlled...

How to Identify Elevated Genetic Risk for Failed AF Ablation (4q25)

Which High-Risk AS Patients Should be Treated with TAVR and Which are Better Suited for Surgical AVR

PFM

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content